GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 32 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,000 | +66.7% | 10,000 | -0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -81.2% | 10,001 | -55.8% | 0.00% | – |
| Q2 2022 | $16,000 | -66.0% | 22,603 | -23.6% | 0.00% | – |
| Q1 2022 | $47,000 | -96.7% | 29,600 | -96.2% | 0.00% | – |
| Q4 2021 | $1,422,000 | +107.6% | 780,654 | +217.9% | 0.00% | – |
| Q3 2021 | $685,000 | +140.4% | 245,583 | +162.4% | 0.00% | – |
| Q2 2021 | $285,000 | +506.4% | 93,584 | +588.2% | 0.00% | – |
| Q1 2021 | $47,000 | -28.8% | 13,599 | -35.1% | 0.00% | – |
| Q4 2020 | $66,000 | -10.8% | 20,966 | +64.2% | 0.00% | – |
| Q4 2019 | $74,000 | +2.8% | 12,768 | -15.5% | 0.00% | – |
| Q3 2019 | $72,000 | -87.7% | 15,119 | -80.9% | 0.00% | – |
| Q2 2019 | $585,000 | +178.6% | 79,335 | +208.6% | 0.00% | – |
| Q1 2019 | $210,000 | +31.2% | 25,705 | +10.2% | 0.00% | – |
| Q4 2018 | $160,000 | 0.0% | 23,333 | +97.7% | 0.00% | – |
| Q3 2018 | $160,000 | +142.4% | 11,800 | -37.5% | 0.00% | – |
| Q4 2016 | $66,000 | – | 18,865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,347,755 | $574,818 | 0.02% |
| Virtu Financial LLC | 31,633 | $13 | 0.00% |
| Western Wealth Management, LLC | 29,537 | $12,597 | 0.00% |
| Belpointe Asset Management LLC | 14,050 | $5,992 | 0.00% |
| TSFG, LLC | 3,000 | $1 | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 100 | $43 | 0.00% |
| Allworth Financial LP | 250 | $107 | 0.00% |
| JANE STREET GROUP, LLC | 13,189 | $5,625 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 138,040 | $58,874 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 500 | $214 | 0.00% |